Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| AMP-Activated Protein Kinases | 5 | 2026 | 170 | 2.350 |
Why?
|
| Tumor Suppressor Protein p53 | 7 | 2019 | 722 | 1.470 |
Why?
|
| Hypocapnia | 1 | 2026 | 3 | 0.980 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2026 | 31 | 0.940 |
Why?
|
| Lysosomes | 2 | 2026 | 267 | 0.930 |
Why?
|
| Carbon Dioxide | 1 | 2026 | 269 | 0.880 |
Why?
|
| Autophagy | 2 | 2026 | 416 | 0.850 |
Why?
|
| Homeostasis | 1 | 2026 | 711 | 0.710 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2020 | 12 | 0.650 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 4646 | 0.580 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2019 | 157 | 0.560 |
Why?
|
| Metformin | 1 | 2020 | 173 | 0.560 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2026 | 976 | 0.500 |
Why?
|
| Signal Transduction | 4 | 2026 | 4663 | 0.480 |
Why?
|
| Embryonic Development | 4 | 2019 | 200 | 0.460 |
Why?
|
| Embryo, Mammalian | 5 | 2019 | 403 | 0.450 |
Why?
|
| Liver Neoplasms | 1 | 2026 | 1367 | 0.450 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2026 | 428 | 0.430 |
Why?
|
| CHARGE Syndrome | 1 | 2014 | 7 | 0.430 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2016 | 356 | 0.420 |
Why?
|
| Mice | 12 | 2026 | 18198 | 0.370 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 2319 | 0.360 |
Why?
|
| Animals | 14 | 2026 | 33725 | 0.350 |
Why?
|
| Phosphorylation | 3 | 2026 | 1570 | 0.330 |
Why?
|
| Abnormalities, Multiple | 1 | 2014 | 962 | 0.280 |
Why?
|
| Lung Neoplasms | 2 | 2016 | 1545 | 0.280 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 2024 | 0.260 |
Why?
|
| Phenotype | 3 | 2019 | 4455 | 0.250 |
Why?
|
| Autophagosomes | 1 | 2026 | 27 | 0.240 |
Why?
|
| Diethylnitrosamine | 1 | 2026 | 20 | 0.240 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2026 | 35 | 0.240 |
Why?
|
| Enzyme Activation | 1 | 2026 | 576 | 0.220 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2026 | 178 | 0.210 |
Why?
|
| Bile Acids and Salts | 1 | 2026 | 260 | 0.200 |
Why?
|
| Protein Biosynthesis | 1 | 2026 | 570 | 0.200 |
Why?
|
| Mice, Knockout | 5 | 2019 | 3819 | 0.190 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2019 | 949 | 0.190 |
Why?
|
| Disease | 1 | 2024 | 121 | 0.190 |
Why?
|
| DNA Damage | 1 | 2026 | 509 | 0.190 |
Why?
|
| Mice, Transgenic | 1 | 2026 | 2323 | 0.160 |
Why?
|
| Metabolism | 1 | 2020 | 45 | 0.160 |
Why?
|
| Gene Knock-In Techniques | 1 | 2020 | 118 | 0.160 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2019 | 16 | 0.150 |
Why?
|
| Neural Crest | 1 | 2019 | 51 | 0.140 |
Why?
|
| DNA Helicases | 2 | 2026 | 238 | 0.140 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2019 | 59 | 0.140 |
Why?
|
| Graft vs Host Disease | 1 | 2024 | 691 | 0.140 |
Why?
|
| Cell Proliferation | 2 | 2016 | 2460 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2016 | 176 | 0.130 |
Why?
|
| Tumor Protein p73 | 1 | 2017 | 26 | 0.130 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2016 | 18 | 0.120 |
Why?
|
| Pyrimidinones | 1 | 2016 | 62 | 0.120 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 477 | 0.120 |
Why?
|
| Thiophenes | 1 | 2016 | 69 | 0.120 |
Why?
|
| DNA-Binding Proteins | 2 | 2014 | 1936 | 0.120 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2024 | 1278 | 0.110 |
Why?
|
| Gene Order | 1 | 2015 | 80 | 0.110 |
Why?
|
| Humans | 7 | 2026 | 130511 | 0.110 |
Why?
|
| Phosphoproteins | 1 | 2017 | 447 | 0.110 |
Why?
|
| Ear | 1 | 2014 | 26 | 0.110 |
Why?
|
| Genotype | 1 | 2020 | 2589 | 0.110 |
Why?
|
| Gene Targeting | 1 | 2015 | 169 | 0.100 |
Why?
|
| Cell Lineage | 1 | 2016 | 344 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2014 | 111 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 196 | 0.100 |
Why?
|
| Maxillofacial Abnormalities | 1 | 2014 | 10 | 0.100 |
Why?
|
| Fatty Acids | 1 | 2016 | 374 | 0.100 |
Why?
|
| Hearing Loss, Conductive | 1 | 2014 | 16 | 0.100 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 560 | 0.100 |
Why?
|
| Mitochondria | 1 | 2019 | 775 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 79 | 0.100 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 382 | 0.100 |
Why?
|
| Trans-Activators | 1 | 2017 | 695 | 0.100 |
Why?
|
| Genetic Loci | 1 | 2015 | 353 | 0.100 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2014 | 80 | 0.100 |
Why?
|
| Inflammation | 1 | 2020 | 1481 | 0.090 |
Why?
|
| Limb Deformities, Congenital | 1 | 2014 | 116 | 0.090 |
Why?
|
| Craniofacial Abnormalities | 1 | 2014 | 251 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 419 | 0.090 |
Why?
|
| Apoptosis | 2 | 2019 | 1821 | 0.090 |
Why?
|
| Heterozygote | 1 | 2014 | 721 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 587 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2014 | 767 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 1207 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2014 | 848 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2015 | 803 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1457 | 0.080 |
Why?
|
| Protein Binding | 1 | 2014 | 1651 | 0.080 |
Why?
|
| Alleles | 1 | 2014 | 1673 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1918 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 3733 | 0.060 |
Why?
|
| RNA Recognition Motif Proteins | 1 | 2026 | 19 | 0.060 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2026 | 28 | 0.060 |
Why?
|
| NAD | 1 | 2026 | 52 | 0.060 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2026 | 62 | 0.060 |
Why?
|
| RNA Helicases | 1 | 2026 | 73 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2026 | 265 | 0.060 |
Why?
|
| Female | 4 | 2019 | 70545 | 0.040 |
Why?
|
| Intestines | 1 | 2024 | 587 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2024 | 905 | 0.040 |
Why?
|
| Yolk Sac | 1 | 2019 | 11 | 0.040 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2019 | 23 | 0.040 |
Why?
|
| Genes, Lethal | 1 | 2019 | 71 | 0.040 |
Why?
|
| Mesoderm | 1 | 2019 | 104 | 0.040 |
Why?
|
| Neural Tube | 1 | 2019 | 38 | 0.040 |
Why?
|
| Acetyltransferases | 1 | 2016 | 74 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2016 | 58 | 0.030 |
Why?
|
| Endoderm | 1 | 2016 | 23 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 1715 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2016 | 156 | 0.030 |
Why?
|
| Placenta | 1 | 2019 | 501 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 208 | 0.030 |
Why?
|
| Heart | 1 | 2019 | 650 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 384 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 1009 | 0.020 |
Why?
|
| Male | 2 | 2019 | 64586 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 4699 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 7475 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 2111 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 6058 | 0.010 |
Why?
|